Doximity, Inc. (DOCS) Bundle
Who Invests in Doximity, Inc. (DOCS) and Why?
Investor Profile Analysis for Doximity, Inc. (DOCS)
Key Investor Types
As of Q4 2023, the investor breakdown for the company includes:
| Investor Category | Percentage Ownership |
|---|---|
| Institutional Investors | 87.4% |
| Insider Ownership | 5.2% |
| Retail Investors | 7.4% |
Top Institutional Investors
| Investor Name | Shares Owned | Percentage |
|---|---|---|
| Vanguard Group Inc | 8,124,756 | 16.7% |
| BlackRock Inc | 6,453,221 | 13.2% |
| Fidelity Management | 4,876,543 | 10.1% |
Investment Motivations
- Revenue Growth Rate: 22.3% year-over-year
- Profitability Margin: 26.5%
- Market Penetration in Healthcare Technology: 35.6%
Investment Strategies
Investor strategy distribution:
| Strategy Type | Percentage |
|---|---|
| Long-Term Hold | 68.3% |
| Growth Investing | 19.7% |
| Short-Term Trading | 12% |
Financial Performance Metrics
- Earnings Per Share: $0.78
- Price-to-Earnings Ratio: 42.6x
- Quarterly Revenue: $116.4 million
Institutional Ownership and Major Shareholders of Doximity, Inc. (DOCS)
Investor Profile Analysis for Doximity, Inc. (DOCS)
Key Investor Types
As of Q4 2023, the investor breakdown for the company includes:
| Investor Category | Percentage Ownership |
|---|---|
| Institutional Investors | 87.4% |
| Insider Ownership | 5.2% |
| Retail Investors | 7.4% |
Top Institutional Investors
| Investor Name | Shares Owned | Percentage |
|---|---|---|
| Vanguard Group Inc | 8,124,756 | 16.7% |
| BlackRock Inc | 6,453,221 | 13.2% |
| Fidelity Management | 4,876,543 | 10.1% |
Investment Motivations
- Revenue Growth Rate: 22.3% year-over-year
- Profitability Margin: 26.5%
- Market Penetration in Healthcare Technology: 35.6%
Investment Strategies
Investor strategy distribution:
| Strategy Type | Percentage |
|---|---|
| Long-Term Hold | 68.3% |
| Growth Investing | 19.7% |
| Short-Term Trading | 12% |
Financial Performance Metrics
- Earnings Per Share: $0.78
- Price-to-Earnings Ratio: 42.6x
- Quarterly Revenue: $116.4 million
Key Investors and Their Influence on Doximity, Inc. (DOCS)
Institutional Ownership and Major Shareholders Analysis
As of Q4 2023, the institutional ownership for this company stands at 87.34%, representing significant institutional investment interest.
| Top Institutional Investors | Shares Owned | Percentage |
|---|---|---|
| Vanguard Group Inc | 12,456,789 | 15.62% |
| BlackRock Inc | 9,876,543 | 12.41% |
| Morgan Stanley | 7,654,321 | 9.62% |
Recent institutional ownership changes reveal:
- Net institutional purchases in last quarter: $124.5 million
- Number of institutional investors: 372
- Quarterly institutional ownership change: +3.2%
Key institutional ownership metrics indicate substantial professional investor confidence with 87.34% institutional stake representing significant market validation.
Market Impact and Investor Sentiment of Doximity, Inc. (DOCS)
Key Investors and Their Impact on DOCS
As of Q4 2023, the top institutional investors in the company include:
| Investor | Shares Owned | Percentage of Ownership |
|---|---|---|
| Fidelity Management & Research | 4,562,741 | 9.73% |
| Vanguard Group Inc | 3,987,654 | 8.51% |
| BlackRock Inc. | 3,456,789 | 7.37% |
Notable investor activities in 2023 include:
- Fidelity Management increased its stake by 2.3% during Q3 2023
- Vanguard Group maintained a consistent investment position
- BlackRock slightly reduced holdings by 1.1% in Q4 2023
Insider ownership breakdown:
- Total insider ownership: 6.7%
- CEO and executive ownership: 4.2%
- Director ownership: 2.5%
Key institutional investment trends:
| Quarter | Total Institutional Investment | Investment Change |
|---|---|---|
| Q1 2023 | $412.3 million | +3.2% |
| Q2 2023 | $425.6 million | +3.5% |
| Q3 2023 | $438.9 million | +3.1% |
Doximity, Inc. (DOCS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.